[ET Net News Agency, 2 February 2024] BRII-B (02137) rose 11.2% to HK$1.79, breaking
above the 10-D SMA of HK$1.747.
It hits an intra-day high of HK$1.79, and an intra-day low of HK$1.63. The total shares
traded was 4.43 million, with a value of HK$7.62m. The active buy/sell ratio is 67:33,
with net buying turnover of HK$2.45m. BARCLAYS CAPITAL ASIA accounts for greatest net
responsive buying turnover of HK$57,005, with volume weighted average price of HK$1.703.
UBS accounts for greatest net responsive selling turnover of HK$705,385, with volume
weighted average price of HK$1.717.
Basic Information
=================
---------------------------------
Nominal 1.790 % Chg +11.18%
High 1.790 Low 1.630
Shares Tr 4.43m Turnover 7.62m
10-D SMA 1.747 %H.V 48.924
20-D SMA 1.906 VWAP 1.719
50-D SMA 2.250 RSI14 40.154
---------------------------------
Status: Breaking above the 10-D SMA, active buy/sell ratio is 67:33, with net buying
turnover of HK$2.45m
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
BRII-B (02137) 1.79 +11.18
HUTCHMED (00013) 20.25 +1.25
GENSCRIPT BIO (01548) 13.94 -1.13
INNOVENT BIO (01801) 33.50 +1.52
WUXI XDC (02268) 21.10 -1.17
WUXI BIO (02269) 20.35 -3.78
BEIGENE (06160) 89.80 -1.10
AKESO (09926) 41.60 +0.36
KINTOR PHARMA-B (09939) 1.70 +41.67
REMEGEN (09995) 17.76 +4.23
-----------------------------------------------
(ed)